Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2012 by Azidus Brasil.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Azidus Brasil
ClinicalTrials.gov Identifier:
NCT01664221
First received: July 25, 2012
Last updated: August 10, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)